Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
about
Dermoscopy in the era of dermato-oncology: from bed to bench side and retour.Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Low to Moderate Incidence: The Rule of 2 vs the Rule of 3.Pathways from senescence to melanoma: focus on MITF sumoylation.IRF4 rs12203592 functional variant and melanoma survival.Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11q
P2860
Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prevalence of MITF p.E318K in ...... of CDKN2A Causative Mutations.
@en
type
label
Prevalence of MITF p.E318K in ...... of CDKN2A Causative Mutations.
@en
prefLabel
Prevalence of MITF p.E318K in ...... of CDKN2A Causative Mutations.
@en
P2093
P50
P1433
P1476
Prevalence of MITF p.E318K in ...... of CDKN2A Causative Mutations.
@en
P2093
Joan Anton Puig-Butille
Julian Conejo-Mir
Luis Javier Del Pozo
P304
P356
10.1001/JAMADERMATOL.2015.4356
P407
P50
P577
2015-12-09T00:00:00Z